Conexeu Sciences Inc.
CNXU- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0002066836
No open-market purchases or sales by Conexeu Sciences Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $278.1K in total; no superinvestor holds it.
Holders of 5% or more of CNXU
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Conexeu Sciences Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Purcell Lynn Sebastian | 13G | 12.30%3.36M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Wright Michael G. | 13G | 12.10%3.28M shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
| Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund | 13G/A | 9.99%4.31M shares | 0.00 ppfrom 9.99% | Sep 4, 20262 filings | Sep 4, 2026 | SEC |
| Bogart David Robert | 13G | 8.10%2.29M shares | New | Aug 18, 20261 filing | Aug 18, 2026 | SEC |
| OnePointTwo Capital Ventures LLC | 13G | 6.80%1.88M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Paisley Capital Holdings Corp | 13G | 6.70%1.80M shares | New | Jul 20, 20261 filing | Jul 20, 2026 | SEC |
| OnePointTwo Capital Ventures II LLC | 13G | 5.50%1.48M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Sharpe Jeffrey Nathan | 13D/A | 5.20%1.50M shares | −0.20 ppfrom 5.40% | Aug 18, 20262 filings | Sep 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Conexeu Sciences Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 20265:25 PM ET | Sharpe Jeffrey Nathan | 13D/A | 5.20%1.50M shares | −0.20 ppfrom 5.40% | Sep 14, 2026 | SEC |
| Sep 4, 202612:00 PM ET | Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund | 13G/A | 9.99%4.31M shares | 0.00 ppfrom 9.99% | Jun 30, 2026 | SEC |
| Sep 4, 202611:49 AM ET | Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund | 13G | 9.99%4.40M shares | New | May 21, 2026 | SEC |
| Aug 18, 20266:04 AM ET | Sharpe Jeffrey Nathan | 13D | 5.40%1.50M shares | New | Jun 18, 2026 | SEC |
| Aug 18, 20266:03 AM ET | Bogart David Robert | 13G | 8.10%2.29M shares | New | Jun 30, 2026 | SEC |
| Aug 14, 20264:32 PM ET | Purcell Lynn Sebastianand 1 other | 13G | 12.30%3.36M shares | New | Jun 30, 2026 | SEC |
| Aug 14, 20264:28 PM ET | OnePointTwo Capital Ventures II LLC | 13G | 5.50%1.48M shares | New | Jun 30, 2026 | SEC |
| Aug 14, 20264:25 PM ET | OnePointTwo Capital Ventures LLC | 13G | 6.80%1.88M shares | New | Jun 30, 2026 | SEC |
| Jul 28, 20261:11 PM ET | Wright Michael G. | 13G | 12.10%3.28M shares | New | Jun 30, 2026 | SEC |
| Jul 20, 202612:33 PM ET | Paisley Capital Holdings Corp | 13G | 6.70%1.80M shares | New | Jun 30, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Conexeu Sciences Inc. shares.
No Form 144 notices for Conexeu Sciences Inc. are on file.